137 related articles for article (PubMed ID: 35970857)
21. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
23. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.
Lee S; Yoon GY; Myoung J; Kim SJ; Ahn DG
Emerg Microbes Infect; 2020 Dec; 9(1):2169-2179. PubMed ID: 32969768
[TBL] [Abstract][Full Text] [Related]
24. Identification of key factors shaping integrated levels of ACE2 and TMPRSS2 expression in head and neck squamous cell carcinoma.
Zheng T; Yue P; Han T; Zhang K; Jiang Y; Wang S; Jiang L; Zhao B; Zhang X; Yan X
Front Biosci (Landmark Ed); 2021 Oct; 26(10):740-751. PubMed ID: 34719202
[No Abstract] [Full Text] [Related]
25. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
27.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract][Full Text] [Related]
28. Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19.
Liu L; Qin JF; Zuo MZ; Zhou Q
J Cell Mol Med; 2022 Feb; 26(3):709-724. PubMed ID: 34951103
[TBL] [Abstract][Full Text] [Related]
29. Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions.
Altaie AM; Hamdy R; Venkatachalam T; Hamoudi R; Soliman SSM
BMC Oral Health; 2021 Nov; 21(1):567. PubMed ID: 34749700
[TBL] [Abstract][Full Text] [Related]
30. Periodontitis promotes the expression of gingival transmembrane serine protease 2 (TMPRSS2), a priming protease for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Ohnishi T; Nakamura T; Shima K; Noguchi K; Chiba N; Matsuguchi T
J Oral Biosci; 2022 Jun; 64(2):229-236. PubMed ID: 35472469
[TBL] [Abstract][Full Text] [Related]
31. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.
Koch J; Uckeley ZM; Doldan P; Stanifer M; Boulant S; Lozach PY
EMBO J; 2021 Aug; 40(16):e107821. PubMed ID: 34159616
[TBL] [Abstract][Full Text] [Related]
32. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
33. Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface.
Collin J; Queen R; Zerti D; Dorgau B; Georgiou M; Djidrovski I; Hussain R; Coxhead JM; Joseph A; Rooney P; Lisgo S; Figueiredo F; Armstrong L; Lako M
Ocul Surf; 2021 Jan; 19():190-200. PubMed ID: 32502616
[TBL] [Abstract][Full Text] [Related]
34. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
Huang C; Jiang Y; Yan J
J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
[TBL] [Abstract][Full Text] [Related]
35. Effect of SARS-CoV-2 Entry Factors on Myeloid Cancers.
Alshareef A
J Nippon Med Sch; 2022; 89(1):95-101. PubMed ID: 35283406
[TBL] [Abstract][Full Text] [Related]
36. Assessment of risk conferred by coding and regulatory variations of
Senapati S; Kumar S; Singh AK; Banerjee P; Bhagavatula S
J Genet; 2020; 99(1):. PubMed ID: 32661206
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway.
Li H; Zhang Y; Hai J; Wang J; Zhao B; Du L; Geng X
Biomed Pharmacother; 2018 Jul; 103():1272-1278. PubMed ID: 29864908
[TBL] [Abstract][Full Text] [Related]
38. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous susceptibility to SARS-CoV-2 infection according to the expression of viral entry factors in the skin.
Garduño-Soto M; Choreño-Parra JA
Gac Med Mex; 2020; 156(4):354-357. PubMed ID: 32831324
[TBL] [Abstract][Full Text] [Related]
40. Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.
Li F; Han M; Dai P; Xu W; He J; Tao X; Wu Y; Tong X; Xia X; Guo W; Zhou Y; Li Y; Zhu Y; Zhang X; Liu Z; Aji R; Cai X; Li Y; Qu D; Chen Y; Jiang S; Wang Q; Ji H; Xie Y; Sun Y; Lu L; Gao D
Nat Commun; 2021 Feb; 12(1):866. PubMed ID: 33558541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
